Tomasz Grabowski

992 total citations
114 papers, 788 citations indexed

About

Tomasz Grabowski is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Tomasz Grabowski has authored 114 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 23 papers in Pharmacology and 20 papers in Molecular Biology. Recurrent topics in Tomasz Grabowski's work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Analytical Methods in Pharmaceuticals (11 papers). Tomasz Grabowski is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (16 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Analytical Methods in Pharmaceuticals (11 papers). Tomasz Grabowski collaborates with scholars based in Poland, United States and Netherlands. Tomasz Grabowski's co-authors include J.J. Jaroszewski, Edmund Grześkowiak, Edyta Szałek, Anna Wolc, M Switała, Maria Cieślak‐Golonka, Gabriela Maciejewska, Joanna Wietrzyk, Walerian Piotrowski and C. Kowalski and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Chemosphere.

In The Last Decade

Tomasz Grabowski

111 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Grabowski Poland 13 190 153 134 84 74 114 788
Nasir Idkaidek Jordan 17 174 0.9× 109 0.7× 111 0.8× 123 1.5× 59 0.8× 70 840
William R. Ravis United States 20 306 1.6× 271 1.8× 156 1.2× 101 1.2× 75 1.0× 116 1.4k
Ben Greijdanus Netherlands 21 396 2.1× 173 1.1× 80 0.6× 41 0.5× 44 0.6× 37 1.2k
A. M. Baars Netherlands 18 407 2.1× 128 0.8× 97 0.7× 70 0.8× 72 1.0× 34 853
Matilde Merino‐Sanjuán Spain 20 96 0.5× 268 1.8× 266 2.0× 76 0.9× 131 1.8× 81 1.4k
Milan Nobilis Czechia 18 235 1.2× 275 1.8× 168 1.3× 223 2.7× 18 0.2× 62 1.1k
Yongmei Li China 18 123 0.6× 316 2.1× 214 1.6× 117 1.4× 86 1.2× 34 1.1k
Richard J. Prankerd Australia 21 143 0.8× 392 2.6× 119 0.9× 84 1.0× 26 0.4× 67 1.3k
Alaa Khedr Egypt 19 230 1.2× 251 1.6× 49 0.4× 56 0.7× 41 0.6× 75 1.2k
Jiangeng Huang China 22 102 0.5× 410 2.7× 258 1.9× 213 2.5× 67 0.9× 76 1.3k

Countries citing papers authored by Tomasz Grabowski

Since Specialization
Citations

This map shows the geographic impact of Tomasz Grabowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Grabowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Grabowski more than expected).

Fields of papers citing papers by Tomasz Grabowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Grabowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Grabowski. The network helps show where Tomasz Grabowski may publish in the future.

Co-authorship network of co-authors of Tomasz Grabowski

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Grabowski. A scholar is included among the top collaborators of Tomasz Grabowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Grabowski. Tomasz Grabowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolc, Anna, et al.. (2024). A Pharmacokinetic Study of the Interaction Between Regorafenib and Paracetamol in Male Rats. Pharmaceutics. 16(11). 1387–1387. 1 indexed citations
2.
Szałek, Edyta, Arkadiusz Spychała, Tomasz Grabowski, et al.. (2022). The metabolic conversion of metamizole (Dipyrone) in male and female patients after total gastrectomy for stomach cancer.. Acta Poloniae Pharmaceutica - Drug Research. 79(3). 401–407.
3.
Tyszka‐Czochara, Małgorzata, Anna Adach, Tomasz Grabowski, et al.. (2021). Selective Cytotoxicity of Complexes with N,N,N-Donor Dipodal Ligand in Tumor Cells. International Journal of Molecular Sciences. 22(4). 1802–1802. 16 indexed citations
4.
Grabowski, Tomasz, et al.. (2021). Ustekinumab pharmacokinetics after subcutaneous administration in swine model. Journal of Veterinary Science. 22(5). e47–e47. 3 indexed citations
5.
Grabowski, Tomasz, et al.. (2020). Effect of siltuximab, omalizumab, infliximab, pembrolizumab and vedolizumab on selected haematological and biochemical parameters in a pig model. Polish Journal of Veterinary Sciences. 23(1). 51–58. 1 indexed citations
6.
Grabowski, Tomasz, et al.. (2020). The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats. Pharmacological Reports. 72(1). 254–259. 6 indexed citations
7.
Stępień–Pyśniak, Dagmara, Anna Gajda, Małgorzata Gbylik‐Sikorska, et al.. (2020). Pharmacokinetics and pharmacodynamics of a single dose of sustained-release azithromycin formulation in pigeons. Polish Journal of Veterinary Sciences. 23(1). 43–50. 2 indexed citations
8.
Grabowski, Tomasz, et al.. (2018). Impact of milk yield on pharmacokinetics of six intramammary drugs – a population approach. Polish Journal of Veterinary Sciences. 21(2). 317–323. 1 indexed citations
9.
Szałek, Edyta, et al.. (2018). The Influence of Diabetes Mellitus on Glucuronidation and Sulphation of Paracetamol in Patients with Febrile Neutropenia. European Journal of Drug Metabolism and Pharmacokinetics. 44(2). 289–294. 2 indexed citations
10.
Grabowski, Tomasz, et al.. (2017). The influence of a single and chronic administration of venlafaxine on tramadol pharmacokinetics in a rabbit model. Pharmacological Reports. 69(3). 555–559. 2 indexed citations
11.
Szałek, Edyta, et al.. (2017). Pharmacokinetic drug-drug interaction between erlotinib and paracetamol: A potential risk for clinical practice. European Journal of Pharmaceutical Sciences. 102. 55–62. 11 indexed citations
13.
Szałek, Edyta, Dawid Murawa, Karol Połom, et al.. (2014). The pharmacokinetics of oral oxycodone in patients after total gastric resection.. PubMed. 18(20). 3126–33. 6 indexed citations
14.
Grabowski, Tomasz, et al.. (2013). Pharmacokinetics of orally administered simvastatin in turkeys. Polish Journal of Veterinary Sciences. 16(2). 377–379. 1 indexed citations
15.
Grabowski, Tomasz, et al.. (2010). Efektywność organizacji IT w bankach : Badanie funkcji IT w bankach.
16.
Grabowski, Tomasz, J.J. Jaroszewski, & Piotr Jakubowski. (2010). Residual fraction of the area under the curve as a qualitative criterion in pharmacokinetic studies. Pharmacological Reports. 62(2). 374–382. 5 indexed citations
17.
Grabowski, Tomasz, Marek Daszkiewicz, Joanna Wietrzyk, et al.. (2010). Silver(I) complexes with hydantoins and allantoin. Journal of Inorganic Biochemistry. 105(1). 17–22. 53 indexed citations
18.
Grabowski, Tomasz, et al.. (2008). Analysis Relationships Between Pharmacokinetic Parameters in silico/in vivo of Selected Antiviral Drugs Based on Structural Analysis. Advances in Clinical and Experimental Medicine. 17(3). 285–292. 3 indexed citations
19.
Wyska, Elżbieta, et al.. (2007). Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis. Pediatric Anesthesia. 17(7). 637–646. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026